Background. A 48-year-old woman with chronic urinary tract infections presented with uremia. Imaging studies revealed bilateral hydronephrosis and segmental ureteral thickening. Investigations.
This phase III two-sided equivalence trial compares 4 and 6 months of TB treatment (2 months of daily treatment with INH, rifampicin, ethambutol and pyrazinamide followed by either 2 or 4 months of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results